CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 8-K/A Event Exhibits
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale · Other events
- UPLOAD Other SEC-generated Letter
- 8-K/A Event Material agreement · Acquisition or sale completed · Unregistered share sale · Auditor change · Change in control · Executive or director change · Shell status change · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Other events
- 8-K Event Bylaws or fiscal year change
- SC 14F1 Other SC 14F1
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Auditor change · Change in control · Executive or director change · Shell status change · Other events
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 4 Open-market buy PRES, CEO, TRES, CFO, SECR bought 250,000 shares at $0.04 ($10,000)
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
Page 75 of 76 · 1,519 filings